Both ZnT1 and ZnT6 are upregulated, and the knockdown of either attenuates cancer cell proliferation by suppressing overlapping signaling pathways, including ERK1/2, p38 MAPK, and NF-κB; while ZnT1 uniquely impacts the mTOR pathway (77). The gene discussed is SLC30A1; the disease is cancer.